Precision medicine based on tumorigenic signaling pathways for triple-negative breast cancer

As a clinically heterogeneous subtype of breast cancer, triple-negative breast cancer (TNBC) is associated with a poor clinical outcome and a high relapse rate. Conventional chemotherapy and radiotherapy are effective treatments for patients with TNBC. However, the prognosis of TNBC remains unsatisf...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Nan, Zhang, Jinghua, Zhao, Jing, Mu, Kun, Zhang, Jun, Jin, Zhao, Yu, Jinpu, Liu, Juntian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144355/
https://www.ncbi.nlm.nih.gov/pubmed/30250564
http://dx.doi.org/10.3892/ol.2018.9290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144355/
https://www.ncbi.nlm.nih.gov/pubmed/30250564
http://dx.doi.org/10.3892/ol.2018.9290

Ejemplares similares